Mitogen-activated protein kinase signaling and drug-induced liver injury: A molecular connection.

Ezhilarasan D, Sharmila M

Open source

DOI
10.1016/j.hbpd.2026.08.009
Published
2026 Aug 27
Container
Hepatobiliary & pancreatic diseases international : HBPD INT
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.hbpd.2026.08.009,
  title = {Mitogen-activated protein kinase signaling and drug-induced liver injury: A molecular connection.},
  author = {Ezhilarasan D and Sharmila M},
  year = {2026},
  journal = {Hepatobiliary \& pancreatic diseases international : HBPD INT},
  doi = {10.1016/j.hbpd.2026.08.009},
  url = {https://doi.org/10.1016/j.hbpd.2026.08.009}
}

RIS

TY  - JOUR
TI  - Mitogen-activated protein kinase signaling and drug-induced liver injury: A molecular connection.
AU  - Ezhilarasan D
AU  - Sharmila M
PY  - 2026
JO  - Hepatobiliary & pancreatic diseases international : HBPD INT
DO  - 10.1016/j.hbpd.2026.08.009
UR  - https://doi.org/10.1016/j.hbpd.2026.08.009
ER  - 

APA

D, E., & M, S. (2026). Mitogen-activated protein kinase signaling and drug-induced liver injury: A molecular connection.. Hepatobiliary & pancreatic diseases international : HBPD INT. https://doi.org/10.1016/j.hbpd.2026.08.009

Source records